These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26167690)

  • 1. Correlates of Initiation of Treatment for Chronic Hepatitis C Infection in United States Veterans, 2004-2009.
    Gundlapalli AV; Nelson RE; Haroldsen C; Carter ME; LaFleur J
    PLoS One; 2015; 10(7):e0132056. PubMed ID: 26167690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peginterferon alfa-2a versus peginterferon alfa-2b as initial treatment of hepatitis C virus infection: a cost-utility analysis from the perspective of the Veterans Affairs Health Care System.
    Yeh WS; Armstrong EP; Skrepnek GH; Malone DC
    Pharmacotherapy; 2007 Jun; 27(6):813-24. PubMed ID: 17542764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C treatment completion rates in routine clinical care.
    Butt AA; McGinnis KA; Skanderson M; Justice AC
    Liver Int; 2010 Feb; 30(2):240-50. PubMed ID: 19889081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment and utilization of rapid virologic response in US veterans with chronic hepatitis C: evaluating provider adherence to practice guidelines.
    Hwang EW; Thomas IC; Cheung R; Backus LI
    J Clin Gastroenterol; 2013 Mar; 47(3):264-70. PubMed ID: 23269309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incident severe thrombocytopenia in veterans treated with pegylated interferon plus ribavirin for chronic hepatitis C infection.
    Hermos JA; Quach L; Gagnon DR; Weber HC; Altincatal A; Cho K; Lawler EV; Grotzinger KM
    Pharmacoepidemiol Drug Saf; 2014 May; 23(5):480-8. PubMed ID: 24677630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retreatment of hepatitis C with consensus interferon and ribavirin after nonresponse or relapse to pegylated interferon and ribavirin: a national VA clinical practice study.
    Yee HS; Currie SL; Tortorice K; Cozen M; Shen H; Chapman S; Cunningham F; Monto A
    Dig Dis Sci; 2011 Aug; 56(8):2439-48. PubMed ID: 21633833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of rapid virological response in hepatitis C therapy in the US veteran population.
    Hwang EW; Thomas IC; Cheung R; Backus LI
    Aliment Pharmacol Ther; 2012 Jan; 35(1):105-15. PubMed ID: 22060887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained virologic response and other potential genotype-specific roles of statins among patients with hepatitis C-related chronic liver diseases.
    Pandya P; Rzouq F; Oni O
    Clin Res Hepatol Gastroenterol; 2015 Oct; 39(5):555-65. PubMed ID: 25835493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of pegylated interferon plus ribavirin for treatment of chronic hepatitis C in Thailand: genotype 1 and 6.
    Kapol N; Lochid-Amnuay S; Teerawattananon Y
    BMC Gastroenterol; 2016 Aug; 16(1):91. PubMed ID: 27492396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-λ3 polymorphisms in pegylated-interferon-α plus ribavirin therapy for genotype-2 chronic hepatitis C.
    Ishiguro H; Abe H; Seki N; Sugita T; Aida Y; Itagaki M; Sutoh S; Shimada N; Furihata T; Tsubota A; Aizawa Y
    World J Gastroenterol; 2015 Apr; 21(13):3904-11. PubMed ID: 25852275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Measure to Assess Variation in Hepatitis C Prevalence Among Homeless and Unstably Housed Veterans, 2011-2016.
    Byrne T; Troszak L; Midboe AM; Fincke BG; Shwartz M; Gifford AL; McInnes DK
    Public Health Rep; 2019; 134(2):126-131. PubMed ID: 30699304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of chronic hepatitis C with peginterferon alfa-2b, plus ribavirin in end stage renal disease patients treated by hemodialysis: single Saudi center experience.
    Alsaran K; Sabry A; Molhem A
    Ren Fail; 2013; 35(10):1305-9. PubMed ID: 24059964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial.
    Liu CH; Huang CF; Liu CJ; Dai CY; Liang CC; Huang JF; Hung PH; Tsai HB; Tsai MK; Chen SI; Lin JW; Yang SS; Su TH; Yang HC; Chen PJ; Chen DS; Chuang WL; Yu ML; Kao JH
    Ann Intern Med; 2013 Dec; 159(11):729-38. PubMed ID: 24297189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engagement in the Hepatitis C Care Cascade Among Homeless Veterans, 2015.
    Noska AJ; Belperio PS; Loomis TP; O'Toole TP; Backus LI
    Public Health Rep; 2017; 132(2):136-139. PubMed ID: 28135425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained HCV clearance by interferon-based therapy reduces hepatocellular carcinoma in hepatitis B and C dually-infected patients.
    Hung CH; Lu SN; Wang JH; Hu TH; Chen CH; Huang CM; Lee CM
    Antivir Ther; 2011; 16(7):959-68. PubMed ID: 22024511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment assessment and predictors of hepatitis C virus treatment in US veterans coinfected with HIV and hepatitis C virus.
    Backus LI; Boothroyd DB; Phillips BR; Mole LA
    J Viral Hepat; 2006 Dec; 13(12):799-810. PubMed ID: 17109679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained virological response rate to pegylated interferon plus ribavirin for chronic hepatitis C in African Americans: results in treatment-naïve patients in a university liver clinic.
    Srivastava S; Bertagnolli M; Lewis JH
    J Natl Med Assoc; 2005 Dec; 97(12):1703-7. PubMed ID: 16396063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of response of US veterans to treatment for the hepatitis C virus.
    Backus LI; Boothroyd DB; Phillips BR; Mole LA
    Hepatology; 2007 Jul; 46(1):37-47. PubMed ID: 17567830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using early viral kinetics to predict antiviral outcome in response-guided pegylated interferon plus ribavirin therapy among patients with hepatitis C virus genotype 1.
    Oze T; Hiramatsu N; Yakushijin T; Miyazaki M; Iio S; Oshita M; Hagiwara H; Mita E; Inui Y; Hijioka T; Inada M; Tamura S; Yoshihara H; Inoue A; Imai Y; Miyagi T; Yoshida Y; Tatsumi T; Kanto T; Kasahara A; Hayashi N; Takehara T
    J Gastroenterol; 2014 Apr; 49(4):737-47. PubMed ID: 23689988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A European single centre experience of management of hepatitis C virus genotype 4 infection with pegylated-interferon and ribavirin.
    Selvapatt N; Habibi MS; Brown A
    J Med Virol; 2015 Oct; 87(10):1716-21. PubMed ID: 25914248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.